CN107090023B - 一种选择性tnfr1拮抗肽sn10及其在类风湿性关节炎中的应用 - Google Patents
一种选择性tnfr1拮抗肽sn10及其在类风湿性关节炎中的应用 Download PDFInfo
- Publication number
- CN107090023B CN107090023B CN201710178435.9A CN201710178435A CN107090023B CN 107090023 B CN107090023 B CN 107090023B CN 201710178435 A CN201710178435 A CN 201710178435A CN 107090023 B CN107090023 B CN 107090023B
- Authority
- CN
- China
- Prior art keywords
- hydrostatin
- peg
- rheumatoid arthritis
- antagonistic peptide
- tnf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (6)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710178435.9A CN107090023B (zh) | 2017-03-23 | 2017-03-23 | 一种选择性tnfr1拮抗肽sn10及其在类风湿性关节炎中的应用 |
PCT/CN2018/077862 WO2018171406A1 (zh) | 2017-03-23 | 2018-03-02 | 选择性tnfr1拮抗肽在制备预防和治疗类风湿性关节炎的药物中的应用 |
JP2020500945A JP6858305B2 (ja) | 2017-03-23 | 2018-03-02 | 関節リウマチを予防及び治療するための薬物の製造における選択性tnfr1拮抗ペプチドの使用 |
EP18770219.6A EP3617223A4 (en) | 2017-03-23 | 2018-03-02 | USE OF THE TNFR1 SELECTIVE ANTAGONIST PEPTIDE SN10 IN THE MANUFACTURING OF MEDICINAL PRODUCTS FOR THE PREVENTION AND TREATMENT OF RHEUMATOID ARTHRITIS |
US16/496,866 US20200188471A1 (en) | 2017-03-23 | 2018-03-02 | Application of selective tnfr1 antagonist peptide sn10 in preparation of drugs for preventing and treating rheumatoid arthritis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710178435.9A CN107090023B (zh) | 2017-03-23 | 2017-03-23 | 一种选择性tnfr1拮抗肽sn10及其在类风湿性关节炎中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107090023A CN107090023A (zh) | 2017-08-25 |
CN107090023B true CN107090023B (zh) | 2020-06-05 |
Family
ID=59648900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710178435.9A Active CN107090023B (zh) | 2017-03-23 | 2017-03-23 | 一种选择性tnfr1拮抗肽sn10及其在类风湿性关节炎中的应用 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20200188471A1 (zh) |
EP (1) | EP3617223A4 (zh) |
JP (1) | JP6858305B2 (zh) |
CN (1) | CN107090023B (zh) |
WO (1) | WO2018171406A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3171807A1 (en) | 2013-12-19 | 2015-06-25 | Illumina, Inc. | Substrates comprising nano-patterning surfaces and methods of preparing thereof |
CN107056921B (zh) * | 2017-03-23 | 2020-06-19 | 桂林八加一药业股份有限公司 | 一种选择性tnfr1拮抗肽sn10及其在炎症性肠病中的应用 |
CN107090023B (zh) * | 2017-03-23 | 2020-06-05 | 桂林八加一药业股份有限公司 | 一种选择性tnfr1拮抗肽sn10及其在类风湿性关节炎中的应用 |
CN108926720A (zh) * | 2018-07-16 | 2018-12-04 | 中山大学附属第三医院(中山大学肝脏病医院) | Tnfr1基因及其编码蛋白的应用 |
CN111763244B (zh) * | 2020-06-24 | 2022-04-05 | 上海大学 | 青环海蛇抗炎活性肽Hydrostatin-SN61及其编码基因和在制药中的应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10316570A (ja) * | 1997-05-13 | 1998-12-02 | Dai Ichi Seiyaku Co Ltd | TNF−α誘導効果阻害剤 |
EP1222925A2 (en) * | 2000-12-18 | 2002-07-17 | Meiji Dairies Corporation | Kavalactone as TNF-alpha production inhibitor |
CN102229654A (zh) * | 2009-10-23 | 2011-11-02 | 山东省医药生物技术研究中心 | 抗类风湿性关节炎的多肽及其在制药中的应用 |
CN103030687B (zh) * | 2013-01-10 | 2014-02-12 | 中国人民解放军第二军医大学 | 青环海蛇抗炎活性肽Hydrostatin-SN1及其编码基因和在制药中的应用 |
CN105031608A (zh) * | 2015-06-23 | 2015-11-11 | 丁兆明 | 一种txndc5短肽在制备抗类风湿性关节炎药物中的应用 |
US9399061B2 (en) * | 2006-04-10 | 2016-07-26 | Abbvie Biotechnology Ltd | Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8362218B2 (en) * | 2009-04-17 | 2013-01-29 | New York University School Of Medicine | Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof |
WO2015104322A1 (en) * | 2014-01-09 | 2015-07-16 | Glaxosmithkline Intellectual Property Development Limited | Treatment of inflammatory diseases with non-competitive tnfr1 antagonists |
CN107090023B (zh) * | 2017-03-23 | 2020-06-05 | 桂林八加一药业股份有限公司 | 一种选择性tnfr1拮抗肽sn10及其在类风湿性关节炎中的应用 |
-
2017
- 2017-03-23 CN CN201710178435.9A patent/CN107090023B/zh active Active
-
2018
- 2018-03-02 JP JP2020500945A patent/JP6858305B2/ja active Active
- 2018-03-02 US US16/496,866 patent/US20200188471A1/en not_active Abandoned
- 2018-03-02 WO PCT/CN2018/077862 patent/WO2018171406A1/zh unknown
- 2018-03-02 EP EP18770219.6A patent/EP3617223A4/en not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10316570A (ja) * | 1997-05-13 | 1998-12-02 | Dai Ichi Seiyaku Co Ltd | TNF−α誘導効果阻害剤 |
EP1222925A2 (en) * | 2000-12-18 | 2002-07-17 | Meiji Dairies Corporation | Kavalactone as TNF-alpha production inhibitor |
US9399061B2 (en) * | 2006-04-10 | 2016-07-26 | Abbvie Biotechnology Ltd | Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis |
CN102229654A (zh) * | 2009-10-23 | 2011-11-02 | 山东省医药生物技术研究中心 | 抗类风湿性关节炎的多肽及其在制药中的应用 |
CN103030687B (zh) * | 2013-01-10 | 2014-02-12 | 中国人民解放军第二军医大学 | 青环海蛇抗炎活性肽Hydrostatin-SN1及其编码基因和在制药中的应用 |
CN105031608A (zh) * | 2015-06-23 | 2015-11-11 | 丁兆明 | 一种txndc5短肽在制备抗类风湿性关节炎药物中的应用 |
Non-Patent Citations (2)
Title |
---|
Screening of an anti-infammatory peptide from Hydrophis cyanocinctus and analysis of its activities and mechanism in DSS-induced acute colitis;Zengjie Z. et al.;《Scientific Reports》;20160509;第1-11页 * |
类风湿性关节炎中肿瘤坏死因子α的表达及意义;陈如平等;《医学综述》;20110305;第647-649页 * |
Also Published As
Publication number | Publication date |
---|---|
EP3617223A1 (en) | 2020-03-04 |
WO2018171406A1 (zh) | 2018-09-27 |
US20200188471A1 (en) | 2020-06-18 |
JP6858305B2 (ja) | 2021-04-14 |
CN107090023A (zh) | 2017-08-25 |
JP2020511544A (ja) | 2020-04-16 |
EP3617223A4 (en) | 2020-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107090023B (zh) | 一种选择性tnfr1拮抗肽sn10及其在类风湿性关节炎中的应用 | |
US8454967B2 (en) | Compositions and methods for modulating the immune system | |
DK2812020T3 (en) | 28 SCHEDOSOMA KDA GST PROTEINS FOR ITS USE IN THE TREATMENT OF INFLAMMATORY AUTO-IMMUNE DISEASES GENERATING A TH1 AND / OR TH17 RESPONSE | |
KR102468907B1 (ko) | 질환의 요인이 되는 생체내 단백질을 표적으로 하는 컨쥬게이트 백신 | |
KR102010793B1 (ko) | 산소 부족 및 공기압 감소에 인한 고산병의 폐 형태의 치료를 위한 약학 조성물 | |
WO2018171405A1 (zh) | 一种选择性tnfr1拮抗肽sn10及其在炎症性肠病中的应用 | |
JPH02479A (ja) | snRNP−A抗原及びそのフラグメント | |
CN103848914B (zh) | 一种具抗凝活性的菲牛蛭素多肽及其制备方法与用途 | |
CN114174332A (zh) | 通过使用抗pre-S1 HBV抗体治疗HBV感染的方法 | |
AU2019240693B2 (en) | Kv1.3 potassium channel antagonists | |
JP2010508027A5 (zh) | ||
CN111763244B (zh) | 青环海蛇抗炎活性肽Hydrostatin-SN61及其编码基因和在制药中的应用 | |
CN114349857B (zh) | 一种Treg细胞制备方法以及在自身免疫性疾病方面的应用 | |
JP5197887B2 (ja) | イミュノグロブリン結合能を有するペプチド | |
CN115073553A (zh) | 一种选择性tnfr1拮抗肽sn61-4g及其在炎症性肠病中的应用 | |
JP2002521387A (ja) | 共重合体1および関連する共重合体ならびにペプチドによる自己免疫疾患の治療 | |
CN114605553A (zh) | 含有Treg细胞的药物组合物以及在自身免疫性疾病中的用途 | |
UA112756C2 (uk) | Комбінована фармацевтична композиція та методи лікування функціональних захворювань або порушень шлунково-кишкового тракту | |
CN106866811A (zh) | 一种鸭嘴兽来源的降钙素及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180129 Address after: 541105 the Guangxi Zhuang Autonomous Region Lingui District Lingui town Guilin vine Tong Industrial Park Luhu international Fantasia E block 2 Building 1 unit 17 room 9-11 Applicant after: GUILIN EIGHT PLUS ONE PHARMACEUTICAL Co.,Ltd. Address before: 200433 No. 1002, room No. 3, Yangpu District, Shanghai City, No. 1002 Applicant before: Lu Yiming |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: No. 10, Mulan North Street, Guilin Economic and Technological Development Zone, Guilin City, Guangxi Zhuang Autonomous Region, 541805 Patentee after: Bajiayi Pharmaceutical Co., Ltd. Address before: Room 9-11, 17th Floor, Unit 1, Building 2, Luhu International Block E, Fantasia Luhu International Block E, Yangtang Industrial Park, Lingui Town, Lingui District, Guilin City, Guangxi Zhuang Autonomous Region, 541105 Patentee before: GUILIN EIGHT PLUS ONE PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Selective TNFR1 Antagonist SN10 and Its Application in Rheumatoid Arthritis Effective date of registration: 20220930 Granted publication date: 20200605 Pledgee: Bank of Liuzhou Co.,Ltd. Guilin Branch Pledgor: Bajiayi Pharmaceutical Co.,Ltd. Registration number: Y2022450000168 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |